Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology FOXO4 DRI Peptide: Support Healthy Cellular Aging Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell FOXO4 DRI 10 mg VPeptide FOXO4 DRI Canada: Ultra Pure Peptide for Senolytic, Cellular Aging & Longevity Pathway Research
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
foxo4-dri senolytic peptide human trial The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI